American drug patents have been implemented since 1984. According to relevant public information, the drug patent linking system originated from the Hatch-Waxman Act of the United States 1984, that is, the listing approval of generic drugs is "linked" to the expiration of innovative drug patents, that is, the patent status of previously listed drugs should be considered when applying for generic drug registration to avoid possible patent infringement.